Johnson & Johnson’s recently made public that its EVP, Global Corp Affairs Broadhurst Vanessa unloaded Company’s shares for reported $1.44 million on Mar 13 ’24. In the deal valued at $162.16 per share,8,891 shares were sold. As a result of this transaction, Broadhurst Vanessa now holds 15,043 shares worth roughly $2.24 million.
Then, JOHNSON & JOHNSON sold 3,725 shares, generating $96,142 in total proceeds. Upon selling the shares at $25.81, the 10% Owner now owns 4,099,575 shares.
Before that, Taubert Jennifer L sold 59,397 shares. Johnson & Johnson shares valued at $9,281,969 were divested by the EVP, WW Chair, Pharmaceuticals at a price of $156.27 per share. As a result of the transaction, Taubert Jennifer L now holds 141,416 shares, worth roughly $21.09 million.
HSBC Securities upgraded its Johnson & Johnson [JNJ] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who decreased its forecast for the stock in mid December from “an Overweight” to “an Equal weight”. UBS also remained covering JNJ and has increased its forecast on December 01, 2023 with a “Buy” recommendation from previously “Neutral” rating. RBC Capital Mkts started covering the stock on October 05, 2023. It rated JNJ as “an Outperform”.
Price Performance Review of JNJ
On Monday, Johnson & Johnson [NYSE:JNJ] saw its stock jump 0.82% to $149.12. Over the last five days, the stock has gained 1.04%. Johnson & Johnson shares have fallen nearly -4.86% since the year began. Nevertheless, the stocks have fallen -8.84% over the past one year. While a 52-week high of $175.97 was reached on 01/22/24, a 52-week low of $143.13 was recorded on 04/18/24. SMA at 50 days reached $155.97, while 200 days put it at $158.41. A total of 9.51 million shares were traded, compared to the trading of 9.75 million shares in the previous session.
Levels Of Support And Resistance For JNJ Stock
The 24-hour chart illustrates a support level at 147.52, which if violated will result in even more drops to 145.93. On the upside, there is a resistance level at 150.49. A further resistance level may holdings at 151.87. The Relative Strength Index (RSI) on the 14-day chart is 40.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.63, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 59.85%. Stochastics %K at 29.85% indicates the stock is a holding.
The most recent change occurred on September 06, 2023 when HSBC Securities began covering the stock and recommended ‘”a Hold”‘ rating along with a $175 price target.
